Member Info for Geovanni

If Molnupiravir is so good how come it isn't on any stage of the ACTIV trial? If anyone can find data on the trial details please upload it.
It wasnt that long ago that GSK/VIR Biotech were saying that VIR7813 was doing well. However ACTIV3 found otherwise and closed the study in March.

Can someone explain this table. Why does a 1000 fold reduction in viral activity mean the ingredient being tested is less active against the variant than a 10 fold reduction. The header title (No Reduction Less Active against variant) seems to imply this contradiction, which doesn't make sense to me.

The point I am making is that there is a webcast and an invitation to brokers. A company doesn't waste the time of brokers if there is nothing new to discuss. We know something new will be revealed, as a minimum it will be interim results and a forward looking statement. The answers to the brokers questions will not be scripted, unlike the answers to shareholder questions on 18 June. We can expect some very good questions and frank answers.

News isn't required to be announced immediately unless there is a risk of other parties revealing it. You don't bring in the broker analysts unless you have a story to tell, which could be released prior to Thursday. Note that they now have high quality PR = no more mistakes.

Thursday webcast and Q&A session for analysts is a very big hint that news is 'imminent'. I expect a big reveal on Thursday. This event should be the most significant positive development since 20 July 2020.

Treatments discussed in the final minutes. Wohl said they are giving monoclonal antibodies to people that are infected and that was all they were giving. He then went on to mention it would be great if there was a pill, or an injection or an inhaled treatment.

The dates of the interim results announcements in the previous 4 years are:

2017 - 27 Sept 2018 - 25 Sept 2019 - 30 Sept 2020 - 29 Sept

No mention of SNG, but Fauci did present t 16 mins a compelling explanation of why a treatment directed from the upper airways down to the lung for a period of a few days is likely to be the best solution.

Could somebody please upload the video where Dr Castro mentioned SNG001 as progressing to Activ 2 Phase 3. Also the time in the video when he said it. I am sure there are a few of us that would like to see it, but missed it when it was first uploaded.

It is encouraging to see Regeneron's product now being used willy nilly in the USA. This bodes well for any other treatment proven to be effective especially so if it doesn't require hospitalisation.

https://www.youtube.com/watch?v=eHH6CZo1JnA

References to gold and gold mining equities being the safe haven in these extraordinary times

Anyone found the data set to justify spending $1.2bn on buying the treatment. I can't find the trial results anywhere

The high volume after 2.30pm suggests the yanks know something and we should be told about it tomorrow.

https://clinicaltrials.gov/ct2/show/NCT04360096

NRx are co-owners of an inhaled treatment for severe covid. This share price performance price bodes well for Synairgen

They are working on developing an inhaled version

It is a relatively small trial (196 persons) but they have the chutzpah to apply for EUA in USA.

They have a drug for Covid and have today announced that a solution has been found for the problem on keeping it stable to prolong its shelf life. Shares have almost doubled since last Friday. M Cap is similar to Synairgen.

https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-announces-first-successful-commercial-formulation-for-zyesami-aviptadil-enabling-volume-manufacture-shipping-and-stockpiling-of-covid-19-medication-subject-to-regulatory-approval-301339154.html

https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00263-0/fulltext

https://www.youtube.com/watch?v=wKlz6qyL0ts&t=458s

Always worth watching to cheer us up. 7:30 to 8:00mins.

https://www.youtube.com/watch?v=1sdIXHwN7Xc